ClariTrial | Search Clinical Trials

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

234 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)

Phase 3Dermatitis, Atopic

611611Matching placebo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.246 participants5 sites · ChinaCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

N/AEczemaAtopic Dermatitis

National Human Genome Research Institute (NHGRI)530 participants1 site · United States

Compare CT.gov Full analysis →

Recruiting

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

Phase 1Psoriasis

HS-20118HS-20118 placebo

Jiangsu Hansoh Pharmaceutical Co., Ltd.132 participants9 sites · United States, New ZealandCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Multi-modal Quantitative Imaging of the Skin

N/ASkin CancerSkin DiseasesAtopic Dermatitis

HJN Sverige AB/Neko Health8,000 participants3 sites · SwedenCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)

N/AAtopic Dermatitis (AD)

Stapokibart

Chengdu Kangnuoxing Biopharma,Inc.1,000 participants1 site · ChinaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Double-blind, Randomized, Non-inferiority Trial in Atopic Dermatitis: Comparison of Lipikar Balm and Relipid+ Balm in the Treatment of Mild to Moderate Atopic Dermatitis in Children and Adults

N/AAtopic DermatitisEmollients

Baume Relipid+

University Hospital, Caen86 participants1 site · FranceCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Phase 1Atopic Dermatitis (AD)Psoriasis (PsO)

LPX-TI641Placebo

LAPIX Therapeutics Inc.48 participants3 sites · United States, JordanCompletes Jan 2026

Compare CT.gov Full analysis →

Recruiting

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

N/AAcneAtopic DermatitisChronic Hand Eczema

Blood samples collectionOral samples collectionHair samples collection+4 more

Innovaderm Research Inc.500 participants1 site · CanadaCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry

N/AChronic Hand Eczema

Observational (Non-Interventional) Registry

CorEvitas2,000 participants1 site · United StatesCompletes Dec 2099

Compare CT.gov Full analysis →

Recruiting

A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab Treatment

N/AAtopic Dermatitis

Dupilumab

Sanofi230 participants9 sites · ItalyCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

Nationwide Research on the Rewilding of Kindergarten Yards

N/AMicrobial ColonizationAtopic DermatitisAsthma in Children

BiodiversityPlayground equipment

Natural Resources Institute Finland320 participants2 sites · FinlandCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

Dupixent and Narrowband UVB for Atopic Dermatitis

Phase 4Atopic Dermatitis

Dupixent

Psoriasis Treatment Center of Central New Jersey40 participants1 site · United StatesCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis

Phase 3Moderate to Severe Atopic Dermatitis

LW402Placebo

Shanghai Longwood Biopharmaceuticals Co., Ltd.480 participants1 site · ChinaCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

Glycyrrhetinic Acid and Acute Irritant Dermatitis

N/AIrritant Contact Dermatitis

SLS induced irritationNo TreatmentPlacebo+3 more

University of Split, School of Medicine30 participants1 site · CroatiaCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

Phase 4Atopic Dermatitis (Eczema)Psoriasis

Sodium chloride tabletsPlacebo Tablets

University of California, San Francisco50 participants2 sites · United StatesCompletes Mar 2028

Compare CT.gov Full analysis →

1–15 of 234

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

234 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)

Phase 3Dermatitis, Atopic

611611Matching placebo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.246 participants5 sites · ChinaCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

N/AEczemaAtopic Dermatitis

National Human Genome Research Institute (NHGRI)530 participants1 site · United States

Compare CT.gov Full analysis →

Recruiting

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

Phase 1Psoriasis

HS-20118HS-20118 placebo

Jiangsu Hansoh Pharmaceutical Co., Ltd.132 participants9 sites · United States, New ZealandCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Multi-modal Quantitative Imaging of the Skin

N/ASkin CancerSkin DiseasesAtopic Dermatitis

HJN Sverige AB/Neko Health8,000 participants3 sites · SwedenCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)

N/AAtopic Dermatitis (AD)

Stapokibart

Chengdu Kangnuoxing Biopharma,Inc.1,000 participants1 site · ChinaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Double-blind, Randomized, Non-inferiority Trial in Atopic Dermatitis: Comparison of Lipikar Balm and Relipid+ Balm in the Treatment of Mild to Moderate Atopic Dermatitis in Children and Adults

N/AAtopic DermatitisEmollients

Baume Relipid+

University Hospital, Caen86 participants1 site · FranceCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Phase 1Atopic Dermatitis (AD)Psoriasis (PsO)

LPX-TI641Placebo

LAPIX Therapeutics Inc.48 participants3 sites · United States, JordanCompletes Jan 2026

Compare CT.gov Full analysis →

Recruiting

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

N/AAcneAtopic DermatitisChronic Hand Eczema

Blood samples collectionOral samples collectionHair samples collection+4 more

Innovaderm Research Inc.500 participants1 site · CanadaCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry

N/AChronic Hand Eczema

Observational (Non-Interventional) Registry

CorEvitas2,000 participants1 site · United StatesCompletes Dec 2099

Compare CT.gov Full analysis →

Recruiting

A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab Treatment

N/AAtopic Dermatitis

Dupilumab

Sanofi230 participants9 sites · ItalyCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

Nationwide Research on the Rewilding of Kindergarten Yards

N/AMicrobial ColonizationAtopic DermatitisAsthma in Children

BiodiversityPlayground equipment

Natural Resources Institute Finland320 participants2 sites · FinlandCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

Dupixent and Narrowband UVB for Atopic Dermatitis

Phase 4Atopic Dermatitis

Dupixent

Psoriasis Treatment Center of Central New Jersey40 participants1 site · United StatesCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis

Phase 3Moderate to Severe Atopic Dermatitis

LW402Placebo

Shanghai Longwood Biopharmaceuticals Co., Ltd.480 participants1 site · ChinaCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

Glycyrrhetinic Acid and Acute Irritant Dermatitis

N/AIrritant Contact Dermatitis

SLS induced irritationNo TreatmentPlacebo+3 more

University of Split, School of Medicine30 participants1 site · CroatiaCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

Phase 4Atopic Dermatitis (Eczema)Psoriasis

Sodium chloride tabletsPlacebo Tablets

University of California, San Francisco50 participants2 sites · United StatesCompletes Mar 2028

Compare CT.gov Full analysis →

1–15 of 234